TruScreen Stakeholder Newsletter

Truscreen Group Limited is pleased to provide a copy of its May 2021 Stakeholders Newsletter.

This gives an update on Truscreen's performance and highlights key initiatives underway.

CY2021 Q1 Key Activities:
• Dual Listed on the ASX with a NZ$2 million capital raise
• Appointment of Juliet Hull as Interim CEO
• Appointment of Dr. Dexter Cheung to The Board
• FY 31 March 2021 SUS sales volume +120% YOY
• China market showing strong recovery
• Commenced clinical evaluation in Saudi Arabia
• Product registration submitted in 4 new markets in Central and Eastern Europe


The Stakeholders Newsletter is available for viewing on the company website http://truscreen.com/investor-centre/newsletters/

ENDS

For more information contact:

Juliet Hull (CEO)
[email protected]

---

Announcement PDF